The use of natural products in colorectal cancer drug discovery

Bibliography

• Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136(5):E359–86
   PubMed Web of Science ®Google Scholar
• Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014. CA Cancer J Clin 2014;64:9–29
   PubMed Web of Science ®Google Scholar
• Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin 2014;64:104–17
   PubMed Web of Science ®Google Scholar
• DeSantis CE, Lin CC, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin 2014;64:252–71
   PubMed Web of Science ®Google Scholar
• Available from: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp#site
   Google Scholar
• Ciombor KK, Wu C, Goldberg RM. Recent therapeutic advances in the treatment of colorectal cancer. Annu Rev Med 2015;66:83–95
   PubMed Web of Science ®Google Scholar
• Brahmer JR, Drake CG, Wollner I, et al. Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates. J Clin Oncol 2010;28:3167–75
   PubMed Web of Science ®Google Scholar
• Lipson EJ, Sharfman WH, Drake CG, et al. Durable cancer regression off-treatment and effective reinduction therapy with an anti-PD-1 antibody. Clin Cancer Res 2013;19:462–8
   PubMed Web of Science ®Google Scholar
• Vosooghi M, Amini M. The discovery and development of cyclooxygenase-2 inhibitors as potential anticancer therapies. Expert Opin Drug Discov 2014;9:255–67
   PubMed Web of Science ®Google Scholar
• Frank E, Koehn Natural products and cancer drug discovery. Springer; New York: 2013
   Google Scholar
• Henkel T, Brunne RM, Muller H, et al. Statistical investigation into the structural complementarity of natural products and synthetic compounds. Angew Chem Int Ed Engl 1999;38:643–7
   PubMed Web of Science ®Google Scholar
• Lovering F, Bikker J, Humblet C. Escape from flatland: increasing saturation as an approach to improving clinical success. J Med Chem 2009;52:6752–6
   PubMed Web of Science ®Google Scholar
• Bravo L. Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr Rev 1998;56:317–33
   PubMed Web of Science ®Google Scholar
• Rusconi M, Conti A. Theobroma cacao L., the Food of the Gods: a scientific approach beyond myths and claims. Pharmacol Res 2010;61:5–13
   PubMed Web of Science ®Google Scholar
• Newman DJ, Cragg GM. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod 2012;75:311–35
   PubMed Web of Science ®Google Scholar
• Bailly C. Ready for a comeback of natural products in oncology. Biochem Pharmacol 2009;77:1447–57
   PubMed Web of Science ®Google Scholar
• Wall ME, Wani MC, Cook CE, et al. Plant antitumor agents. I. The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from Camptotheca acuminate. J Am Chem Soc 1966;88:3888–90
   Web of Science ®Google Scholar
• Hsiang YH, Liu LF. Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin. Cancer Res 1988;48:1722–6
   PubMed Web of Science ®Google Scholar
• Gottlieb JA, Luce JK. Treatment of malignant melanoma with camptothecin (NSC-100880). Cancer Chemother Rep 1972;56:103–5
   PubMedGoogle Scholar
• Kroep JR, Gelderblom H. Diflomotecan, a promising homocamptothecin for cancer therapy. Expert Opin Investig Drugs 2009;18:69–75
   PubMed Web of Science ®Google Scholar
• Prada CF, Alvarez-Velilla R, Balaña-Fouce R, et al. Gimatecan and other camptothecin derivatives poison Leishmania DNA-topoisomerase IB leading to a strong leishmanicidal effect. Biochem Pharmacol 2013;85:1433–40
   PubMed Web of Science ®Google Scholar
• Maehara Y, Tsujitani S, Saeki H, et al. Biological mechanism and clinical effect of protein-bound polysaccharide K (KRESTIN(®)): review of development and future perspectives. Surg Today 2012;42:8–28
   PubMed Web of Science ®Google Scholar
• Lu H, Yang Y, Gad E, et al. Polysaccharide krestin is a novel TLR2 agonist that mediates inhibition of tumor growth via stimulation of CD8 T cells and NK cells. Clin Cancer Res 2011;17:67–76
   PubMed Web of Science ®Google Scholar
• Available from: http://www.fda.gov/
   Google Scholar
• Vareed SK, Kakarala M, Ruffin MT, et al. Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects. Cancer Epidemiol Biomarkers Prev 2008;17:1411–17
   PubMed Web of Science ®Google Scholar
• Sandur SK, Deorukhkar A, Pandey MK, et al. Curcumin modulates the radiosensitivity of colorectal cancer cells by suppressing constitutive and inducible NF-kappaB activity. Int J Radiat Oncol Biol Phys 2009;75:534–42
   PubMed Web of Science ®Google Scholar
• Kunnumakkara AB, Diagaradjane P, Anand P, et al. Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model. Int J Cancer 2009;125:2187–97
   PubMed Web of Science ®Google Scholar
• Kunnumakkara AB, Diagaradjane P, Guha S, et al. Curcumin sensitizes human colorectal cancer xenografts in nude mice to gamma-radiation by targeting nuclear factor-kappaB-regulated gene products. Clin Cancer Res 2008;14:2128–36
   PubMed Web of Science ®Google Scholar
• Howells LM, Sale S, Sriramareddy SN, et al. Curcumin ameliorates oxaliplatin-induced chemoresistance in HCT116 colorectal cancer cells in vitro and in vivo. Int J Cancer 2011;129:476–86
   PubMed Web of Science ®Google Scholar
• Lustig RA, Vogl TJ, Fromm D, et al. A multicenter Phase I safety study of intratumoral photoactivation of talaporfin sodium in patients with refractory solid tumors. Cancer 2003;98:1767–71
   PubMed Web of Science ®Google Scholar
• Kujundzić M, Vogl TJ, Stimac D, et al. A Phase II safety and effect on time to tumor progression study of intratumoral light infusion technology using talaporfin sodium in patients with metastatic colorectal cancer. J Surg Oncol 2007;96:518–24
   PubMed Web of Science ®Google Scholar
• Cockbain AJ, Volpato M, Race AD, et al. Anticolorectal cancer activity of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid. Gut 2014;63(11):1760–8
   PubMed Web of Science ®Google Scholar
• D’Angelo L, Piazzi G, Pacilli A, et al. A combination of eicosapentaenoic acid-free fatty acid, epigallocatechin-3-gallate and proanthocyanidins has a strong effect on mTOR signaling in colorectal cancer cells. Carcinogenesis 2014;35(10):2314–20
   PubMed Web of Science ®Google Scholar
• Piazzi G, D’Argenio G, Prossomariti A, et al. Eicosapentaenoic acid free fatty acid prevents and suppresses colonic neoplasia in colitis-associated colorectal cancer acting on Notch signaling and gut microbiota. Int J Cancer 2014;135:2004–13
   PubMed Web of Science ®Google Scholar
• Fini L, Piazzi G, Ceccarelli C, et al. Highly purified eicosapentaenoic acid as free fatty acids strongly suppresses polyps in Apc(Min/+) mice. Clin Cancer Res 2010;16:5703–11
   PubMed Web of Science ®Google Scholar
• Howells LM, Berry DP, Elliott PJ, et al. Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases–safety, pharmacokinetics, and pharmacodynamics. Cancer Prev Res (Phila) 2011;4:1419–25
   PubMed Web of Science ®Google Scholar
• Liu W, Guo W, Guo L, et al. Andrographolide sulfonate ameliorates experimental colitis in mice by inhibiting Th1/Th17 response. Int Immunopharmacol 2014;20:337–45
   PubMed Web of Science ®Google Scholar
• Deng S, Hu B, An HM, et al. Teng-Long-Bu-Zhong-Tang, a Chinese herbal formula, enhances anticancer effects of 5–Fluorouracil in CT26 colon carcinoma. BMC Complement Altern Med 2013;13:128
   PubMedGoogle Scholar
• Lam W, Bussom S, Guan F, et al. The four-herb Chinese medicine PHY906 reduces chemotherapy-induced gastrointestinal toxicity. Sci Transl Med 2010;2:45ra59
   PubMed Web of Science ®Google Scholar
• Stingl JC, Ettrich T, Muche R, et al. Protocol for minimizing the risk of metachronous adenomas of the colorectum with green tea extract (MIRACLE): a randomised controlled trial of green tea extract versus placebo for nutriprevention of metachronous colon adenomas in the elderly population. BMC Cancer 2011;11:360
   PubMed Web of Science ®Google Scholar
• West NJ, Clark SK, Phillips RK, et al. Eicosapentaenoic acid reduces rectal polyp number and size in familial adenomatous polyposis. Gut 2010;59:918–25
   PubMed Web of Science ®Google Scholar
• Hull MA, Sandell AC, Montgomery AA, et al. A randomized controlled trial of eicosapentaenoic acid and/or aspirin for colorectal adenoma prevention during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme (The seAFOod Polyp Prevention Trial): study protocol for a randomized controlled trial. Trials 2013;14:237
   PubMedGoogle Scholar
• Wang LS, Burke CA, Hasson H, et al. A phase Ib study of the effects of black raspberries on rectal polyps in patients with familial adenomatous polyposis. Cancer Prev Res (Phila) 2014;7:666–74
   PubMed Web of Science ®Google Scholar
• Carroll RE, Benya RV, Turgeon DK, et al. Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia. Cancer Prev Res (Phila) 2011;4:354–64
   PubMed Web of Science ®Google Scholar
• Brown VA, Patel KR, Viskaduraki M, et al. Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis. Cancer Res 2010;70:9003–11
   PubMed Web of Science ®Google Scholar
• Patel KR, Brown VA, Jones DJ, et al. Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. Cancer Res 2010;70:7392–9
   PubMed Web of Science ®Google Scholar
• Boocock DJ, Faust GE, Patel KR, et al. Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiol Biomarkers Prev 2007;16:1246–52
   PubMed Web of Science ®Google Scholar
• Hope C, Planutis K, Planutiene M, et al. Low concentrations of resveratrol inhibit Wnt signal throughput in colon-derived cells: implications for colon cancer prevention. Mol Nutr Food Res 2008;52 Suppl 1:S52–61
   PubMed Web of Science ®Google Scholar
• Nguyen AV, Martinez M, Stamos MJ, et al. Results of a phase I pilot clinical trial examining the effect of plant-derived resveratrol and grape powder on Wnt pathway target gene expression in colonic mucosa and colon cancer. Cancer Manag Res 2009;1:25–37
   PubMedGoogle Scholar
• Murff HJ, Shu XO, Li H, et al. A prospective study of dietary polyunsaturated fatty acids and colorectal cancer risk in Chinese women. Cancer Epidemiol Biomarkers Prev 2009;18:2283–91
   PubMed Web of Science ®Google Scholar
• Zick SM, Turgeon DK, Vareed SK, et al. Phase II study of the effects of ginger root extract on eicosanoids in colon mucosa in people at normal risk for colorectal cancer. Cancer Prev Res (Phila) 2011;4:1929–37
   PubMed Web of Science ®Google Scholar
• Citronberg J, Bostick R, Ahearn T, et al. Effects of ginger supplementation on cell-cycle biomarkers in the normal-appearing colonic mucosa of patients at increased risk for colorectal cancer: results from a pilot, randomized, and controlled trial. Cancer Prev Res (Phila) 2013;6:271–81
   PubMed Web of Science ®Google Scholar
• Jiang Y, Turgeon DK, Wright BD, et al. Effect of ginger root on cyclooxygenase-1 and 15-hydroxyprostaglandin dehydrogenase expression in colonic mucosa of humans at normal and increased risk for colorectal cancer. Eur J Cancer Prev 2013;22:455–60
   PubMed Web of Science ®Google Scholar
• Zick SM, Turgeon DK, Ren J, et al. Pilot clinical study of the effects of ginger root extract on eicosanoids in colonic mucosa of subjects at increased risk for colorectal cancer. Mol Carcinog 2014. [Epub ahead of print]
   PubMedGoogle Scholar
• Larrosa M, González-Sarrías A, Yáñez-Gascón MJ, et al. Anti-inflammatory properties of a pomegranate extract and its metabolite urolithin-A in a colitis rat model and the effect of colon inflammation on phenolic metabolism. J Nutr Biochem 2010;21:717–25
   PubMed Web of Science ®Google Scholar
• Huu Tung N, Du GJ, Wang CZ, et al. Naphthoquinone components from Alkanna tinctoria (L.) Tausch show significant antiproliferative effects on human colorectal cancer cells. Phytother Res 2013;27:66–70
   PubMed Web of Science ®Google Scholar
• Chitchumroonchokchai C, Thomas-Ahner JM, Li J, et al. Anti-tumorigenicity of dietary α-mangostin in an HT-29 colon cell xenograft model and the tissue distribution of xanthones and their phase II metabolites. Mol Nutr Food Res 2013;57:203–11
   PubMed Web of Science ®Google Scholar
• Zhang W, Sviripa V, Kril LM, et al. Fluorinated N,N-dialkylaminostilbenes for Wnt pathway inhibition and colon cancer repression. J Med Chem 2011;54:1288–97
   PubMed Web of Science ®Google Scholar
• Imai M, Kikuchi H, Denda T, et al. Cytotoxic effects of flavonoids against a human colon cancer derived cell line, COLO 201: a potential natural anti-cancer substance. Cancer Lett 2009;276:74–80
   PubMed Web of Science ®Google Scholar
• Suh Y, Afaq F, Johnson JJ, et al. A plant flavonoid fisetin induces apoptosis in colon cancer cells by inhibition of COX2 and Wnt/EGFR/NF-kappaB-signaling pathways. Carcinogenesis 2009;30:300–7
   PubMed Web of Science ®Google Scholar
• Shimizu M, Adachi S, Masuda M, et al. Cancer chemoprevention with green tea catechins by targeting receptor tyrosine kinases. Mol Nutr Food Res 2011;55:832–43
   PubMed Web of Science ®Google Scholar
• Yuan JH, Li YQ, Yang XY. Protective effects of epigallocatechin gallate on colon preneoplastic lesions induced by 2-amino-3-methylimidazo[4,5-f ]quinoline in mice. Mol Med 2008;14:590–8
   PubMed Web of Science ®Google Scholar
• Thomasset S, Berry DP, Cai H, et al. Pilot study of oral anthocyanins for colorectal cancer chemoprevention. Cancer Prev Res (Phila) 2009;2:625–33
   PubMed Web of Science ®Google Scholar
• Lim S, Xu J, Kim J, et al. Role of anthocyanin-enriched purple-fleshed sweet potato p40 in colorectal cancer prevention. Mol Nutr Food Res 2013;57:1908–17
   PubMed Web of Science ®Google Scholar
• Ponnurangam S, Mammen JM, Ramalingam S, et al. Honokiol in combination with radiation targets notch signaling to inhibit colon cancer stem cells. Mol Cancer Ther 2012;11:963–72
   PubMed Web of Science ®Google Scholar
• Kang YJ, Park HJ, Chung HJ, et al. Wnt/β-catenin signaling mediates the antitumor activity of magnolol in colorectal cancer cells. Mol Pharmacol 2012;82:168–77
   PubMed Web of Science ®Google Scholar
• Min HY, Chung HJ, Kim EH, et al. Inhibition of cell growth and potentiation of tumor necrosis factor-α (TNF-α)-induced apoptosis by a phenanthroindolizidine alkaloid antofine in human colon cancer cells. Biochem Pharmacol 2010;80:1356–64
   PubMed Web of Science ®Google Scholar
• Yang X, Shi Q, Yang SC, et al. Antitumor agents 288: design, synthesis, SAR, and biological studies of novel heteroatom-incorporated antofine and cryptopleurine analogues as potent and selective antitumor agents. J Med Chem 2011;54:5097–107
   PubMed Web of Science ®Google Scholar
• Reyes-Zurita FJ, Rufino-Palomares EE, Lupiáñez JA, et al. Maslinic acid, a natural triterpene from Olea europaea L., induces apoptosis in HT29 human colon-cancer cells via the mitochondrial apoptotic pathway. Cancer Lett 2009;273:44–54
   PubMed Web of Science ®Google Scholar
• Puangpraphant S, Dia VP, de Mejia EG, et al. Yerba mate tea and mate saponins prevented azoxymethane-induced inflammation of rat colon through suppression of NF-κB p65ser(311) signaling via IκB-α and GSK-3β reduced phosphorylation. Biofactors 2013;39:430–40
   PubMed Web of Science ®Google Scholar
• Li Y, Sun Y, Fan L, et al. Paris saponin VII inhibits growth of colorectal cancer cells through Ras signaling pathway. Biochem Pharmacol 2014;88:150–7
   PubMed Web of Science ®Google Scholar
• Chicca A, Pellati F, Adinolfi B, et al. Cytotoxic activity of polyacetylenes and polyenes isolated from roots of Echinacea pallida. Br J Pharmacol 2008;153:879–85
   PubMed Web of Science ®Google Scholar
• Macone A, Lendaro E, Comandini A, et al. Chromane derivatives of small aromatic molecules: chemoenzymatic synthesis and growth inhibitory activity on human tumor cell line LoVo WT. Bioorg Med Chem 2009;17:6003–7
   PubMed Web of Science ®Google Scholar
• Luo XJ, Li LL, Deng QP, et al. Grifolin, a potent antitumour natural product upregulates death-associated protein kinase 1 DAPK1 via p53 in nasopharyngeal carcinoma cells. Eur J Cancer 2011;47:316–25
   PubMed Web of Science ®Google Scholar
• Kim SP, Kang MY, Nam SH, et al. Dietary rice bran component γ-oryzanol inhibits tumor growth in tumor-bearing mice. Mol Nutr Food Res 2012;56:935–44
   PubMed Web of Science ®Google Scholar
• Zhang R, Wang Y, Li J, et al. The Chinese herb isolate yuanhuacine (YHL-14) induces G2/M arrest in human cancer cells by up-regulating p21 protein expression through an p53 protein-independent cascade. J Biol Chem 2014;289:6394–403
   PubMed Web of Science ®Google Scholar
• Ueberschaar N, Xu Z, Scherlach K, et al. Synthetic remodeling of the chartreusin pathway to tune antiproliferative and antibacterial activities. J Am Chem Soc 2013;135:17408–16
   PubMed Web of Science ®Google Scholar
• Lee SJ, Lee I, Lee J, et al. Statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, potentiate the anti-angiogenic effects of bevacizumab by suppressing angiopoietin2, BiP, and Hsp90α in human colorectal cancer. Br J Cancer 2014;111:497–505
   PubMed Web of Science ®Google Scholar
• Yamazaki H, Rotinsulu H, Kaneko T, et al. A new dibenz[b,e]oxepine derivative, 1-hydroxy-10-methoxy-dibenz[b,e]oxepin-6,11-dione, from a marine-derived fungus, Beauveria bassiana TPU942. Mar Drugs 2012;10:2691–7
   PubMed Web of Science ®Google Scholar
• Femia AP, Luceri C, Bianchini F, et al. Marie Ménard apples with high polyphenol content and a low-fat diet reduce 1,2-dimethylhydrazine-induced colon carcinogenesis in rats: effects on inflammation and apoptosis. Mol Nutr Food Res 2012;56:1353–7
   PubMed Web of Science ®Google Scholar
• Liu L, Li YH, Niu YB, et al. An apple oligogalactan prevents against inflammation and carcinogenesis by targeting LPS/TLR4/NF-κB pathway in a mouse model of colitis-associated colon cancer. Carcinogenesis 2010;31:1822–32
   PubMed Web of Science ®Google Scholar
• Bi X, Fang W, Wang LS, et al. Black raspberries inhibit intestinal tumorigenesis in apc1638+/- and Muc2-/- mouse models of colorectal cancer. Cancer Prev Res (Phila) 2010;3:1443–50
   PubMed Web of Science ®Google Scholar
• González-Vallinas M, Molina S, Vicente G, et al. Antitumor effect of 5-fluorouracil is enhanced by rosemary extract in both drug sensitive and resistant colon cancer cells. Pharmacol Res 2013;72:61–8
   PubMed Web of Science ®Google Scholar
• Scherlach K, Hertweck C. Triggering cryptic natural product biosynthesis in microorganisms. Org Biomol Chem 2009;7:1753–60
   PubMed Web of Science ®Google Scholar
• Mohr JT, Krout MR, Stoltz BM. Natural products as inspiration for the development of asymmetric catalysis. Nature 2008;455:323–32
   PubMed Web of Science ®Google Scholar
• Morrison KC, Hergenrother PJ. Natural products as starting points for the synthesis of complex and diverse compounds. Nat Prod Rep 2014;31:6–14
   PubMed Web of Science ®Google Scholar
• Kirschning A, Hahn F. Merging chemical synthesis and biosynthesis: a new chapter in the total synthesis of natural products and natural product libraries. Angew Chem Int Ed Engl 2012;51:4012–22
   PubMed Web of Science ®Google Scholar
• Thomas GL, Johannes CW. Natural product-like synthetic libraries. Curr Opin Chem Biol 2011;15:516–22
   PubMed Web of Science ®Google Scholar
• Schmitt EK, Moore CM, Krastel P, et al. Natural products as catalysts for innovation: a pharmaceutical industry perspective. Curr Opin Chem Biol 2011;15:497–504
   PubMed Web of Science ®Google Scholar
• Mitchell W. Natural products from synthetic biology. Curr Opin Chem Biol 2011;15:505–15
   PubMed Web of Science ®Google Scholar
• Weber W, Fussenegger M. The impact of synthetic biology on drug discovery. Drug Discov Today 2009;14:956–63
   PubMed Web of Science ®Google Scholar
• Zurbriggen MD, Moor A, Weber W. Plant and bacterial systems biology as platform for plant synthetic bio(techno)logy. J Biotechnol 2012;160:80–90
   PubMed Web of Science ®Google Scholar
• Over B, Wetzel S, Grütter C, et al. Natural-product-derived fragments for fragment-based ligand discovery. Nat Chem 2013;5:21–8
   PubMed Web of Science ®Google Scholar
• Mitchell W, Matsumoto S. Large-scale integrated super-computing platform for next generation virtual drug discovery. Curr Opin Chem Biol 2011;15:553–9
   PubMed Web of Science ®Google Scholar
• Shoichet BK. Drug discovery: nature’s pieces. Nat Chem 2013;5:9–10
   PubMed Web of Science ®Google Scholar
• Lachance H, Wetzel S, Kumar K, et al. Charting, navigating, and populating natural product chemical space for drug discovery. J Med Chem 2012;55:5989–6001
   PubMed Web of Science ®Google Scholar
• Skropeta D, Wei L. Recent advances in deep-sea natural products. Nat Prod Rep 2014;31:999–1025
   PubMed Web of Science ®Google Scholar
• Dancík V, Seiler KP, Young DW, et al. Distinct biological network properties between the targets of natural products and disease genes. J Am Chem Soc 2010;132:9259–61
   PubMed Web of Science ®Google Scholar